PA
VKTX icon

Profund Advisors’s Viking Therapeutics VKTX Stock Holding History

Profund Advisors’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.89M Sell
48,407
-6,572
-12% -$212K 0.05% 207
2026
Q1 		$1.79M Sell
54,979
-904
-2% -$29.1K 0.07% 231
2025
Q4 		$1.97M Buy
55,883
+14,772
+36% +$523K 0.06% 221
2025
Q3 		$1.08M Buy
41,111
+9,715
+31% +$290K 0.04% 311
2025
Q2 		$832K Sell
31,396
-4,980
-14% -$131K 0.03% 341
2025
Q1 		$878K Sell
36,376
-13,392
-27% -$423K 0.04% 326
2024
Q4 		$2M Buy
49,768
+1,770
+4% +$101K 0.07% 183
2024
Q3 		$3.04M Sell
47,998
-11,587
-19% -$680K 0.12% 137
2024
Q2 		$3.16M Buy
59,585
+37,997
+176% +$2.49M 0.12% 131
2024
Q1 		$1.77M Sell
21,588
-45,965
-68% -$2.05M 0.07% 191
2023
Q4 		$1.26M Sell
67,553
-26,465
-28% -$346K 0.05% 280
2023
Q3 		$1.04M Buy
94,018
+31,330
+50% +$448K 0.06% 273
2023
Q2 		$1.02M Sell
62,688
-35,528
-36% -$744K 0.05% 311
2023
Q1 		$1.64M Buy
+98,216
New +$1.01M 0.1% 171

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Profund Advisors's VKTX Position: Q2 2026 in Review

Profund Advisors reduced its Viking Therapeutics (VKTX) stake by 12% in Q2 2026, selling an estimated $212K and leaving 48,407 shares worth $1.89M. The position accounts for 0.05% of the portfolio, ranked #207.

Profund Advisors first reported a position in VKTX in Q1 2023 and has held it in 14 quarters since. The position peaked at $3.16M in Q2 2024. 434 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Profund Advisors held 48,407 shares of Viking Therapeutics worth $1.89M as of Q2 2026.
  • Profund Advisors sold 6,572 Viking Therapeutics shares in Q2 2026, an estimated $212K.
  • Viking Therapeutics made up 0.05% of Profund Advisors's portfolio in Q2 2026, its #207 holding.
  • Profund Advisors first reported a position in Viking Therapeutics in Q1 2023 and has held it in 14 quarters since.
  • Profund Advisors's Viking Therapeutics position peaked at $3.16M in Q2 2024.
  • 434 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Profund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.